Edition:
United States

Veloxis Pharmaceuticals A/S (VELOX.CO)

VELOX.CO on Copenhagen Stock Exchange

1.18DKK
22 Jul 2016
Change (% chg)

kr.0.02 (+1.72%)
Prev Close
kr.1.16
Open
kr.1.17
Day's High
kr.1.18
Day's Low
kr.1.14
Volume
943,766
Avg. Vol
1,835,481
52-wk High
kr.2.10
52-wk Low
kr.0.93

VELOX.CO

Chart for VELOX.CO

About

Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, is a Denmark-based company active in the biotechnology and pharmaceutical industry. It is primarily focused on the development of its transplant immunosuppression product candidate, LCP-Tacro. LCP-Tacro is being developed as a once-daily dosage version of tacrolimus for... (more)

Overall

Beta: 0.14
Market Cap(Mil.): kr.2,013.41
Shares Outstanding(Mil.): 1,699.07
Dividend: --
Yield (%): --

Financials

  VELOX.CO Industry Sector
P/E (TTM): -- 39.80 37.05
EPS (TTM): -0.12 -- --
ROI: -142.55 -5.86 14.35
ROE: -142.55 -4.70 15.56

BRIEF-Veloxis Pharmaceuticals raises DKK 4.1 mln from exercise of warrants

* Capital increase from exercise of warrants amounts to 4.1 million Danish crowns ($620,977)

Jun 13 2016

BRIEF-Veloxis Pharmaceuticals Q1 operating loss at $6.9 mln

* Said on Wednesday Q1 revenue $1.5 million versus $647,000 year ago

May 19 2016

BRIEF-Veloxis Pharmaceuticals appoints Michael Thomas Heffernan new chairman

* Board of directors constituted itself with Michael Thomas Heffernan as chairman of board

Apr 06 2016

BRIEF-Veloxis Pharmaceuticals: Johnny Stilou to step down as EVP & CFO

* Johnny Stilou will step down as EVP & Chief Financial Officer as part of the Company's decision to close down all Danish activities and move to the US

Apr 06 2016

BRIEF-Veloxis FY operating loss widens to DKK 197.1 million

* FY revenue 14.2 million Danish crowns ($2.1 million) versus 123.4 million crowns year ago

Mar 09 2016

BRIEF-Veloxis Pharmaceuticals moves Danish activities to the U.S.

* Veloxis Pharmaceuticals has decided to close its office in Hørsholm, Denmark, and move all activities to the U.S. where most of the company's current activities is already located

Mar 09 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.